APA (7th ed.) Citation

Takeuchi, Y., Kato, H., Horiguchi, S., Oyama, A., Adachi, T., Wada, N., . . . Takaki, A. (2022). Study Protocol for a Trial: A Single-Arm, Open-Labeled Study Evaluating Transcatheter Arterial Embolization Plus Everolimus Combination Therapy for Patients With Liver Metastasis of Gastroenteropancreatic Neuroendocrine Tumors. Clinical Medicine Insights: Oncology, 1. https://doi.org/10.1177/11795549221127750

Chicago Style (17th ed.) Citation

Takeuchi, Yasuto, Hironari Kato, Shigeru Horiguchi, Atsushi Oyama, Takuya Adachi, Nozomu Wada, Hideki Onishi, Hidenori Shiraha, and Akinobu Takaki. "Study Protocol for a Trial: A Single-Arm, Open-Labeled Study Evaluating Transcatheter Arterial Embolization Plus Everolimus Combination Therapy for Patients With Liver Metastasis of Gastroenteropancreatic Neuroendocrine Tumors." Clinical Medicine Insights: Oncology 2022: 1. https://doi.org/10.1177/11795549221127750.

MLA (9th ed.) Citation

Takeuchi, Yasuto, et al. "Study Protocol for a Trial: A Single-Arm, Open-Labeled Study Evaluating Transcatheter Arterial Embolization Plus Everolimus Combination Therapy for Patients With Liver Metastasis of Gastroenteropancreatic Neuroendocrine Tumors." Clinical Medicine Insights: Oncology, 2022, p. 1, https://doi.org/10.1177/11795549221127750.